Brief report · 29 Dec 2025
Conference abstractPublished 15 Apr 2014
Assessment of serum based molecular marker creditworthy for early diagnosed type 2 Diabetes
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he most important purpose in diabetes diagnosis is its initial detection and treatment, in order to forbid the frequency and development of diabetes specific complications. Proteomic technologies play an important role in drug discovery, diagnostics and molecular medicine because of the link between genes, proteins and disease. New generation diagnostic platforms, like commercially available kits have enabled to measure accurate blood glucose level that predict diabetic condition, helping to define diagnosis and the most appropriate therapies. However, hematological evaluation of specimens obtained from blood of the patients is the gold standard of diagnosis. To demonstrate the biomarkers associated with early diagnosed type 2 diabetes, subjects are carefully selected by measuring the blood glucose HbA1C level at fasting period. Samples from the subjects are ultra-centrifuged to winnow out the large abundant protein like Globulin and Albumin. Low abundant serum proteins are then separated through chromatographic fractional analysis with 2D liquid chromatography based on charge and hydrophobicity. Ultimately for the characterization of molecular marker mass spectroscopic analysis are done. This analysis provides for measurement of the peptide fragment masses generated by trypsin digestion of the protein where the mass resolution is a measure of a spectrometer?s capability to produce separate signals of ions of similar mass. Finally, having obtained the molecular weight, pI, and peptide fingerprints of the biomarkers of interest, identification are accomplished throughout the peptident tool database.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Biomarkers & Diagnosis.
Commentary · 29 Dec 2025
Molecular Diagnostics: Revolutionizing Precision Healthcare
Commentary · 29 Dec 2025
Genomic Biomarkers Revolutionizing Disease Diagnosis and Medicine
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Biomarkers & Diagnosis
- SubjectGenetics & Molecular Biology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Md. Mahmodul Islam”
